DAFNA Capital Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-143,600
| Closed | -$4.71M | – | 97 |
|
|
2022
Q2 | $4.71M | Sell |
143,600
-47,035
| -25% | -$1.49M | 1.28% | 25 |
|
|
2022
Q1 | $5.01M | Hold |
190,635
| – | – | 1.31% | 23 |
|
|
2021
Q4 | $4.52M | Buy |
190,635
+94,982
| +99% | +$2.34M | 1.14% | 27 |
|
|
2021
Q3 | $2.4M | Hold |
95,653
| – | – | 0.64% | 43 |
|
|
2021
Q2 | $2.48M | Hold |
95,653
| – | – | 0.52% | 43 |
|
|
2021
Q1 | $2.45M | Buy |
95,653
+10,078
| +12% | +$258K | 0.58% | 42 |
|
|
2020
Q4 | $1.72M | Buy |
85,575
+42,675
| +99% | +$836K | 0.51% | 43 |
|
|
2020
Q3 | $735K | Hold |
42,900
| – | – | 0.24% | 65 |
|
|
2020
Q2 | $936K | Hold |
42,900
| – | – | 0.27% | 58 |
|
|
2020
Q1 | $992K | Hold |
42,900
| – | – | 0.41% | 48 |
|
|
2019
Q4 | $1.42M | Hold |
42,900
| – | – | 0.49% | 49 |
|
|
2019
Q3 | $1.37M | Hold |
42,900
| – | – | 0.51% | 51 |
|
|
2019
Q2 | $1.1M | Hold |
42,900
| – | – | 0.41% | 57 |
|
|
2019
Q1 | $1.09M | Buy |
42,900
+5,000
| +13% | +$149K | 0.47% | 48 |
|
|
2018
Q4 | $1.29M | Hold |
37,900
| – | – | 0.64% | 40 |
|
|
2018
Q3 | $1.35M | Hold |
37,900
| – | – | 0.55% | 46 |
|
|
2018
Q2 | $1.31M | Hold |
37,900
| – | – | 0.61% | 44 |
|
|
2018
Q1 | $1.27M | Buy |
37,900
+30,000
| +380% | +$949K | 0.62% | 41 |
|
|
2017
Q4 | $302K | Hold |
7,900
| – | – | 0.16% | 64 |
|
|
2017
Q3 | $296K | Hold |
7,900
| – | – | 0.18% | 61 |
|
|
2017
Q2 | $295K | Buy |
+7,900
| New | +$285K | 0.21% | 60 |
|
Other funds holding NTUS
DAFNA Capital Management's NTUS Position: Q3 2022 in Review
DAFNA Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 143,600 shares — an estimated $4.71M sold.
DAFNA Capital Management first reported a position in NTUS in Q2 2017 and held it in 21 quarters. The position peaked at $5.01M in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- DAFNA Capital Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- DAFNA Capital Management sold 143,600 Natus Medical Inc shares in Q3 2022, an estimated $4.71M.
- DAFNA Capital Management first reported a position in Natus Medical Inc in Q2 2017 and held it in 21 quarters.
- DAFNA Capital Management's Natus Medical Inc position peaked at $5.01M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on DAFNA Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.